DiaKine Therapeutics, Inc. Report issue

For profit Phase 2
Founded: Norfolk VA United States (2004)
Status: Acquired by Islet Sciences (2012)

Organization Overview

First Clinical Trial
2009
NCT00896077
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

lisofylline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1